Candriam S.C.A. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001537014

What is a 13F filing? Who files one and when · What 13F filings can't tell you

LargeTechnology TiltHigh Turnover how tags are computed

Q3 2024 · 648 positions · Total reported value $16.76B · Top-10 concentration 30.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 47.4% · 21 new · 252 cut · 51 exited

Active Share (vs S&P 500): 37.1% · vs QQQ: 52.6% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -0.6% · vs SPY -2.8% · Prev Value $22.00B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -1.7% · vs SPY -3.9% · Latest Value $22.25B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2024 13F filing, Candriam S.C.A. disclosed 648 equity positions with a combined reported value of $16.76B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 30.9% of reported value. HoldingsHub classifies the profile as Large / Technology Tilt / High Turnover.

The largest disclosed positions as of Q3 2024 were MSFT ($1.09B), NVDA ($853.12M), AAPL ($829.09M). By sector, the heaviest allocations are Technology 35.1%, Health Care 24.1%. Versus the prior quarter, allocation shifted toward Health Care (+1.3pp), Industrials (+0.8pp) and away from Technology (-1.9pp).

Versus the prior quarter, Candriam S.C.A. opened 21 new positions, trimmed 252 and fully exited 51, a turnover rate of 47.4% of positions. The portfolio's overlap with the prior quarter was 89% of names.

The largest new positions opened in Q3 2024 were SMMT ($18.62M), THC ($14.88M), RNAM ($14.85M).

Of the 51 positions fully exited versus the prior quarter, the largest were LRCX ($121.94M), LW ($21.69M), ALLY ($12.76M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2024)

  • SMMT SUMMIT THERAPEUTICS INC · $18.62M
  • THC TENET HEALTHCARE CORP · $14.88M
  • RNAM AVIDITY BIOSCIENCES INC · $14.85M
  • SE SEA LTD · $13.30M
  • FERG FERGUSON ENTERPRISES INC · $12.83M
  • ITCI INTRA CELLULAR THERAPIES INC · $12.01M
  • YPF YPF · $11.17M
  • ONTO ONTO INNOVATION INC · $10.81M

Fully Exited (vs previous quarter)

  • LRCX LAM RESEARCH · prev qtr: $121.94M · history
  • LW LAMB WESTON HLDGS INC · prev qtr: $21.69M
  • ALLY ALLY FINL INC · prev qtr: $12.76M
  • CLDX CELLDEX THERAPEUTICS INC NEW · prev qtr: $11.75M
  • WRK WESTROCK CO · prev qtr: $11.72M
  • BLK BLACKROCK INC · prev qtr: $9.35M
  • ARES ARES MANAGEMENT CORPORATION · prev qtr: $9.17M
  • VIPS VIPSHOP HLDGS LTD · prev qtr: $8.05M

Insider Transactions (Form 4)

Latest Candriam S.C.A. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Candriam S.C.A. is a Luxembourg-based asset management firm founded in 1989, now part of New York Life Investments, with headquarters in Strassen, Luxembourg. The firm employs a responsible investment approach integrating ESG factors across various asset classes.

Investment Approach

Responsible investment with ESG integration, combining quantitative and fundamental research, offering both active and passive investment strategies

Asset Classes

Equities, fixed income, alternatives, multi-asset solutions

Notable Facts

Part of New York Life Investments, strong focus on sustainable investing, acquired in 2018

AUM

$154.7B (SEC Form ADV regulatory figure)

Official disclosures available through SEC filings

Sector Allocation

Technology 35.1%
Health Care 24.1%
Financials 7.2%
Utilities 2.6%
Other 6.3%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 2.54M $1.09B 6.52%
6.52%
Add
2 7.03M $853.12M 5.09%
5.09%
Add
3 3.56M $829.09M 4.95%
4.95%
Hold
4 3.17M $525.87M 3.14%
3.14%
Add
5 505.90K $448.18M 2.67%
2.67%
Add
6 1.81M $337.38M 2.01%
2.01%
Add
7 494.94K $289.37M 1.73%
1.73%
Add
8 2.47M $279.99M 1.67%
1.67%
Add
9 252.53K $265.45M 1.58%
1.58%
Add
10 813.10K $261.98M 1.56%
1.56%
Add
11 412.88K $203.87M 1.22%
1.22%
Hold
12 328.98K $203.49M 1.21%
1.21%
Reduce
13 739.02K $203.18M 1.21%
1.21%
Reduce
14 1.11M $192.22M 1.15%
1.15%
Add
15 1.07M $185.29M 1.11%
1.11%
Reduce
16 651.06K $178.19M 1.06%
1.06%
Add
17 2.09M $175.07M 1.04%
1.04%
Add
18 994.34K $166.24M 0.99%
0.99%
Add
19 170.13K $152.15M 0.91%
0.91%
Hold
20 864.01K $150.05M 0.90%
0.90%
Add
21 902.36K $148.05M 0.88%
0.88%
Add
22 311.31K $144.78M 0.86%
0.86%
Reduce
23 354.53K $143.65M 0.86%
0.86%
Reduce
24 638.36K $132.52M 0.79%
0.79%
Add
25 1.04M $114.20M 0.68%
0.68%
Add
26 541.46K $114.17M 0.68%
0.68%
Add
27 230.23K $113.10M 0.68%
0.68%
Reduce
28 927.16K $110.11M 0.66%
0.66%
Add
29 643.28K $109.39M 0.65%
0.65%
Add
30 554.34K $108.30M 0.65%
0.65%
Add
31 399.42K $104.49M 0.62%
0.62%
Reduce
32 379.79K $102.93M 0.61%
0.61%
Add
33 47.82K $98.13M 0.59%
0.59%
Reduce
34 352.27K $97.93M 0.58%
0.58%
Reduce
35 463.44K $93.63M 0.56%
0.56%
Reduce
36 1.14M $92.65M 0.55%
0.55%
Reduce
37 389.00K $92.18M 0.55%
0.55%
Hold
38 160.10K $91.64M 0.55%
0.55%
Reduce
39 336.24K $91.18M 0.54%
0.54%
Reduce
40 347.73K $88.23M 0.53%
0.53%
Add
41 339.82K $86.76M 0.52%
0.52%
Reduce
42 763.13K $79.14M 0.47%
0.47%
Reduce
43 1.05M $77.33M 0.46%
0.46%
Add
44 431.43K $77.15M 0.46%
0.46%
Add
45 387.22K $76.47M 0.46%
0.46%
Add
46 1.41M $75.10M 0.45%
0.45%
Reduce
47 410.40K $74.14M 0.44%
0.44%
Reduce
48 541.03K $73.05M 0.44%
0.44%
Add
49 428.22K $72.82M 0.43%
0.43%
Add
50 263.95K $72.71M 0.43%
0.43%
Add

FAQ

What did Candriam S.C.A. buy in 2024-Q3?

In its 2024-Q3 13F filing, Candriam S.C.A. reported 648 equity positions worth $16.76B in aggregate; its largest disclosed positions were MSFT ($1.09B), NVDA ($853.12M), AAPL ($829.09M).

How large is Candriam S.C.A.'s portfolio?

Candriam S.C.A. reported $16.76B of long equity holdings across 648 positions as of 2024-Q3. Top-10 holdings account for 30.9% of reported value.

What is Candriam S.C.A.'s investment style?

HoldingsHub classifies the portfolio as Large / Technology Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/candriam-s-c-a/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →